Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Br J Cancer. 1995 Jan; 71(1): 109–114.
doi: 10.1038/bjc.1995.22
PMCID: PMC2033480
PMID: 7819025

Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status.

Y. M. Hsueh, G. S. Cheng, M. M. Wu, H. S. Yu, T. L. Kuo, and C. J. Chen
Author information Copyright and License information PMC Disclaimer

Abstract

In order to evaluate the prevalence and multiple risk factors of arsenic-induced skin cancer among residents in Taiwanese villages in which chronic arseniasis is hyperendemic, a total of 1571 subjects aged 30 or more years were recruited between September 1988 and March 1989. All of them were interviewed personally by a public health nurse using a structured questionnaire, and 1081 interviewed study subjects, including 468 men and 613 women, participated in physical examination, giving a participation rate of 68.8%. The overall prevalence of skin cancer was as high as 6.1%, showing an increase with age in both men and women. There was a significant dose-response relation between skin cancer prevalence and chronic arsenic exposure as indexed by duration of residence in the endemic area, duration of consumption of high-arsenic artesian well water, average arsenic exposure in parts per million (p.p.m.) and cumulative arsenic exposure in p.p.m.-years. Chronic carriers of hepatitis B surface antigen with liver dysfunction had an increased prevalence of skin cancer. Undernourishment, indexed by a high consumption of dried sweet potato as a staple food, was also significantly associated with an increased prevalence of arsenic-induced skin cancer. All these risk factors remained statistically significant in the multiple logistic regression analysis. Consistent with animal experiments, the findings imply that liver function and nutritional status may affect the metabolism of inorganic arsenic and the development of subsequent skin cancers.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 109
109
icon of scanned page 110
110
icon of scanned page 111
111
icon of scanned page 112
112
icon of scanned page 113
113
icon of scanned page 114
114
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Brownstein MH, Rabinowitz AD. The precursors of cutaneous squamous cell carcinoma. Int J Dermatol. 1979 Jan-Feb;18(1):1–16. [PubMed] [Google Scholar]
  • Buchet JP, Lauwerys R. Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol Appl Pharmacol. 1987 Oct;91(1):65–74. [PubMed] [Google Scholar]
  • Buchet JP, Geubel A, Pauwels S, Mahieu P, Lauwerys R. The influence of liver disease on the methylation of arsenite in humans. Arch Toxicol. 1984 Sep;55(3):151–154. [PubMed] [Google Scholar]
  • Cebrián ME, Albores A, Aguilar M, Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum Toxicol. 1983 Jan;2(1):121–133. [PubMed] [Google Scholar]
  • Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985 Nov;45(11 Pt 2):5895–5899. [PubMed] [Google Scholar]
  • Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988 Sep-Oct;8(5):452–460. [PubMed] [Google Scholar]
  • Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992 Nov;66(5):888–892. [PMC free article] [PubMed] [Google Scholar]
  • Deng JS, How SW. Comparison of the fine structure of basal cell carcinomas in ordinary patients and patients with chronic arsenicalism. Taiwan Yi Xue Hui Za Zhi. 1977 Sep;76(9):685–692. [PubMed] [Google Scholar]
  • Frost DV. Arsenicals in biology--retrospect and prospect. Fed Proc. 1967 Jan-Feb;26(1):194–208. [PubMed] [Google Scholar]
  • Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 1990 Sep 15;46(3):356–361. [PubMed] [Google Scholar]
  • Jacobson-Kram D, Montalbano D. The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ Mutagen. 1985;7(5):787–804. [PubMed] [Google Scholar]
  • Lee TC, Oshimura M, Barrett JC. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis. 1985 Oct;6(10):1421–1426. [PubMed] [Google Scholar]
  • Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC. Induction of gene amplification by arsenic. Science. 1988 Jul 1;241(4861):79–81. [PubMed] [Google Scholar]
  • Nelson WC, Lykins MH, Mackey J, Newill VA, Finklea JF, Hammer DI. Mortality among orchard workers exposed to lead arsenate spray: a cohort study. J Chronic Dis. 1973 Feb;26(2):105–118. [PubMed] [Google Scholar]
  • SOMMERS SC, MCMANUS RG. Multiple arsenical cancers of skin and internal organs. Cancer. 1953 Mar;6(2):347–359. [PubMed] [Google Scholar]
  • Tam GK, Charbonneau SM, Bryce F, Pomroy C, Sandi E. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol Appl Pharmacol. 1979 Sep 15;50(2):319–322. [PubMed] [Google Scholar]
  • Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 1968 Mar;40(3):453–463. [PubMed] [Google Scholar]
  • Vahter M, Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem Biol Interact. 1983 Oct 15;47(1):29–44. [PubMed] [Google Scholar]
  • Vahter M, Marafante E. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett. 1987 Jun;37(1):41–46. [PubMed] [Google Scholar]
  • Vahter M, Marafante E, Dencker L. Tissue distribution and retention of 74As-dimethylarsinic acid in mice and rats. Arch Environ Contam Toxicol. 1984 May;13(3):259–264. [PubMed] [Google Scholar]
  • Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H, Ng SK, Munoz B, Emmett EA. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990 Jun 15;65(12):2811–2817. [PubMed] [Google Scholar]
  • Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989 Dec;130(6):1123–1132. [PubMed] [Google Scholar]
  • Yeh S. Skin cancer in chronic arsenicism. Hum Pathol. 1973 Dec;4(4):469–485. [PubMed] [Google Scholar]
  • Yeh S, How SW, Lin CS. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer. 1968 Feb;21(2):312–339. [PubMed] [Google Scholar]
Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK
-